Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

De-Escalation of Antiplatelet Therapy to Evaluate Platelet Reactivity and Clinical Outcomes After Coronary Stenting in Patients at High Bleeding Risk and Recent Acute Coronary Syndrome: DESC-HBR Trial

NCT05903976 is registered in ClinicalTrials.gov with Azienda Ospedaliera Universitaria Policlinico "G. Martino" as lead sponsor.

NCT NCT05903976
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05903976 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
De-Escalation of Antiplatelet Therapy to Evaluate Platelet Reactivity and Clinical Outcomes After Coronary Stenting in Patients at High Bleeding Risk and Recent Acute Coronary Syndrome: DESC-HBR Trial
Lead sponsor
Azienda Ospedaliera Universitaria Policlinico "G. Martino"
Phase
Phase 3
Overall status
Unknown status
Start date
June 12, 2023
Completion date
October 30, 2025
Enrollment
200 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, coronary artery disease, dual antiplatelet therapy